RIAN NINA JAFFER: Open Payments
NPI 1841407798 · LOMA LINDA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$617 in 24 payments from 14 companies in 2025. Trend: 2023 $675 · 2024 $818 · 2025 $617
Food & beverage: $522Education: $95
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 3 | $133 |
| Arcutis Biotherapeutics, Inc. | 3 | $68 |
| LEO Pharma Inc. | 3 | $65 |
| UCB, Inc. | 2 | $53 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $51 |
| Amgen Inc. | 2 | $46 |
| GENZYME CORPORATION | 1 | $44 |
| Lilly USA, LLC | 2 | $41 |
| Incyte Corporation | 1 | $25 |
| Janssen Biotech, Inc. | 1 | $24 |
Products named: DUPIXENT, Zoryve, ADBRY, Bimzelx, SPEVIGO, Otezla, TALTZ, OPZELURA.
Industry payments across CA — which companies pay providers there.
